This week in Britain, a landmark historical move to ban puberty blockers in gender clinics has been motioned and overseen by the National Health Service of England (NHS). They will no longer be prescribed to children at gender clinics.
These are drugs used to delay the onset of puberty in adolescent children typically administered to individuals who identify as LGBT and wish to transform their biological gender.
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in